Associate Laboratory Director Gracio Testifies Before House Science, Space & Technology Subcommittees
WASHINGTON, June 15 -- The House Science, Space and Technology Subcommittee on Energy released the following written testimony by Deborah Gracio, associate laboratory director for the National Security Directorate at the Pacific Northwest National Laboratory, from a June 5, 2025, joint hearing with the Subcommittee on Research and Technology entitled "Pursuing the Golden Age of Innovation: Strategic Priorities in Biotechnology":
* * *
Chairman Weber, Chairman Obernolte, Ranking Member Ross, Ra more
Catholic University of America Law Professor Testifies Before Senate Judiciary Subcommittees
WASHINGTON, June 15 -- The Senate Judiciary Subcommittee on the Constitution released the following testimony by Jose Joel Alicea, a law professor at the Catholic University of America, from a June 3, 2025, joint hearing with the Subcommittee on Federal Courts, Oversight, Agency Action and Federal Rights entitled "The Supposedly "Least Dangerous Branch": District Judges v. Trump":
* * *
Mr. Chairman, Ranking Member, and Members of the Subcommittees: Thank you for the invitation to testify toda more
Great Lakes Research Center Associate Director Techtmann Testifies Before House Science, Space & Technology Subcommittees
WASHINGTON, June 15 -- The House Science, Space and Technology Subcommittee on Energy released the following written testimony by Steve Techtmann, an associate professor of environmental microbiology and associate director of the Great Lakes Research Center at Michigan Technological University, from a June 5, 2025, joint hearing with the Subcommittee on Research and Technology entitled "Pursuing the Golden Age of Innovation: Strategic Priorities in Biotechnology":
* * *
1. Introduction
First, more
National Institute for Innovation in Manufacturing Biopharmaceuticals Director Lee Testifies Before House Science Subcommittees
WASHINGTON, June 15 -- The House Science, Space and Technology Subcommittee on Energy released the following written testimony by Kelvin H. Lee, director of the National Institute for Innovation in Manufacturing Biopharmaceuticals, from a June 5, 2025, joint hearing with the Subcommittee on Research and Technology entitled "Pursuing the Golden Age of Innovation: Strategic Priorities in Biotechnology":
* * *
Chair Babin, Ranking Member Lofgren, Chair Obernolte, Ranking Member Stevens, Chair Web more
South Texas College of Law Houston Chair Blackman Testifies Before Senate Judiciary Subcommittees
WASHINGTON, June 15 -- The Senate Judiciary Subcommittee on the Constitution released the following written testimony by Josh Blackman, chair of constitutional law at the South Texas College of Law Houston, from a June 3, 2025, joint hearing with the Subcommittee on Federal Courts, Oversight, Agency Action and Federal Rights entitled "The Supposedly "Least Dangerous Branch": District Judges v. Trump":
* * *
Chairman Cruz and Chairman Schmitt, Ranking Member Whitehouse and Ranking Member Welch, more
Stanford University Fellow Endy Testifies Before House Science, Space & Technology Subcommittees
WASHINGTON, June 15 -- The House Science, Space and Technology Subcommittee on Energy released the following written testimony by Drew Endy, a fellow in undergraduate education for bioengineering at Stanford University, from a June 5, 2025, joint hearing with the Subcommittee on Research and Technology entitled "Pursuing the Golden Age of Innovation: Strategic Priorities in Biotechnology":
* * *
WHY BIOTECHNOLOGY MATTERS AS A TECHNOLOGY
Biology is the next-to-mature general purpose technology more
University of Pennsylvania Law Professor Testifies Before Senate Judiciary Subcommittees
WASHINGTON, June 15 -- The Senate Judiciary Subcommittee on the Constitution released the following written testimony by Kate Shaw, a law professor at the University of Pennsylvania, from a June 3, 2025, joint hearing with the Subcommittee on Federal Courts, Oversight, Agency Action and Federal Rights entitled "The Supposedly "Least Dangerous Branch": District Judges v. Trump":
* * *
Chairman Cruz, Ranking Member Whitehouse, Chairman Schmitt, Ranking Member Welch, and Distinguished Members of more
Tipoffs: Congressional Research Service Reports (W)
Tipoffs: Congressional Testimony
Tipoffs: Financials Weekly
Tipoffs: GAO Reports Weekly
Tipoffs: Grants Opportunities Weekly
Tipoffs: Law Firm Representation
Tipoffs: Patents Weekly
Tipoffs: Personnel Changes
Tipoffs: President Trump & Congress
Tipoffs: President Trump & Education
Tipoffs: President Trump & Energy
Tipoffs: President Trump & Federal Agencies
Tipoffs: President Trump & Public Policy Groups
Tipoffs: President Trump & States
Tipoffs: President Trump & Tariffs
Tipoffs: President Trump & Ukraine
Tipoffs: Research from Colleges in Academic Journals
Tipoffs: Research from International Colleges
Tipoffs: Research from U.S. Colleges
Public Comments on Proposed Federal Rules
U.S. Drug Supply Chains Face Deep Vulnerabilities, Company Warns
WASHINGTON, June 15 -- On Demand Pharmaceuticals, Rockville, Maryland, has submitted an analysis to the U.S. Department of Commerce Bureau of Industry and Security, outlining vulnerabilities within the nation's drug supply chains. The company states that the availability of essential medicines rests on assumptions that no longer hold, masking deeper issues across economic, structural and geopolitical lines.
The company's assessment highlights that the U.S. heavily relies on global supply chains more
BioMarin Seeks Tariff Exclusion for Orphan Drugs
WASHINGTON, June 14 -- BioMarin Pharmaceutical Inc., San Rafael, California, has asked the U.S. Department of Commerce Bureau of Industry and Security to exclude orphan drugs and their components from any tariffs or import restrictions stemming from an ongoing Section 232 investigation into pharmaceutical imports. The biopharmaceutical company argues such an exclusion is justified due to the nature of orphan drugs and their market.
G. Eric Davis, executive vice president and chief legal officer more
Center for Individual Freedom Calls for Targeted Approach to Drug Import Tariffs
WASHINGTON, June 14 -- The Center for Individual Freedom has submitted comments to the U.S. Department of Commerce Bureau of Industry and Security, advocating for a judicious application of Section 232 of the Trade Expansion Act of 1962 to protect the nation's pharmaceutical supply chain. The non-profit organization urges a calibrated strategy that mitigates risks from adversarial nations while preserving relationships with trusted allies.
The Center highlighted that America leads in pharmaceut more
Horse Owner Raises Concerns Over Proposed Federal Horse Protection Rule
WASHINGTON, June 14 -- Julia Baca, a lifelong horse owner, exhibitor, volunteer and community leader from Santa Fe, New Mexico, has submitted comments to the U.S. Department of Agriculture Animal and Plant Health Inspection Service regarding its proposed amendments to the Horse Protection Act. Baca argues that broad implementation of the rule could adversely affect horse organizations that already prioritize animal welfare.
"Part of why I compete with and value these groups is because of the st more
Japan Urges U.S. Against Pharmaceutical Tariffs
WASHINGTON, June 14 -- The Government of Japan has submitted comments to the U.S. Department of Commerce Bureau of Industry and Security, urging against tariffs on pharmaceuticals and their ingredients. These comments, part of a Commerce investigation into pharmaceutical import effects on national security, highlight these products as critical to national security.
The Japanese government contends it would be challenging for the U.S. to establish complete domestic manufacturing for all pharmace more
Japanese Pharma Group Warns Against U.S. Tariffs
WASHINGTON, June 14 -- The Japan Pharmaceutical Manufacturers Association has submitted comments to the U.S. Department of Commerce Bureau of Industry and Security, opposing tariffs on pharmaceuticals and ingredients under a national security investigation. The association stressed its commitment to ensuring a stable supply of medicines vital to health security in both Japan and the U.S.
The Japanese industry group highlighted a long history of zero tariffs between the nations, suggesting this more
U.S. Pharma Manufacturer Warns on Import Threats
WASHINGTON, June 14 -- Alora Pharmaceuticals LLC, Alpharetta, Georgia, has submitted comments to the U.S. Department of Commerce Bureau of Industry and Security, regarding its Section 232 national security investigation on pharmaceutical imports. The company highlighted severe challenges posed by foreign competition to domestic production.
Harold Arthur Deas Jr., CEO of Alora, explained the difficulty U.S. manufacturers face: "The market for Venlafaxine ER tablets is extremely competitive, with more
Tipoffs: Artificial Intelligence
Senator Markey Hosts Fireside Chat on AI and Civil Rights with Massachusetts Advocates, Community Leaders
WASHINGTON, June 13 -- Sen. Edward J. Markey, D-Massachusetts, issued the following news release:
* * *
Senator Markey Hosts Fireside Chat on AI and Civil Rights with Massachusetts Advocates, Community Leaders
*
Washington (June 13, 2025) - Senator Edward J. Markey (D-Mass.), a member of the Commerce, Science, and Transportation Committee, today hosted a fireside chat with Massachusetts advocates and community leaders to discuss artificial intelligence (AI), civil rights, and the Senator's A more